Plymouth, MN – According to filings with the U.S. Securities and Exchange Commission, Monteris Medical US is raising $6,136,275.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, James Erickson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Monteris Medical US

Monteris is a private equity backed neurosurgical company focused solely on diseases of the brain. The company was founded in Winnipeg, Canada in 1999 to create neurosurgical technology that, when used by neurosurgeons, would allow them to ablate brain tumors and lesions that may be difficult to approach via traditional methods. The NeuroBlate System is a minimally invasive robotically controlled laser thermotherapy that uses MRI-guided laser light to ablate (destroy) unwanted tissue in the brain where the lesion, or abnormal tissue, originates.

To learn more about Monteris Medical US, visit http://www.monteris.com/

Contact:
James Erickson, Chief Financial Officer
204-272-2220
jerickson@monteris.com
https://www.linkedin.com/in/jim-erickson-6654137/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved